Evidence map›Paper›PMID 40846662›Full record

ArticleAlcohol, clinical & experimental research2025

Plasma apolipoproteins and memory function in alcohol use disorder: Findings in male C57BL/6J mice and men suggest a role for APOAI.

Berta Escudero, Max Kreifeldt, Kiera Fleck, Catherine Lopez, Candice Contet, Laura Orio

Abstract read
In one paragraph

Article in Alcohol, clinical & experimental research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Berta EscuderoDepartment of Psychobiology and Behavioral Sciences Methods, Faculty of Psychology, Complutense University of Madrid, Madrid, Spain.
Max KreifeldtThe Scripps Research Institute, Department of Translational Medicine, La Jolla, California, USA.
Kiera FleckThe Scripps Research Institute, Department of Translational Medicine, La Jolla, California, USA.
Catherine LopezThe Scripps Research Institute, Department of Translational Medicine, La Jolla, California, USA.
Candice ContetThe Scripps Research Institute, Department of Translational Medicine, La Jolla, California, USA.ORCID https://orcid.org/0000-0002-4459-9540
Laura OrioDepartment of Psychobiology and Behavioral Sciences Methods, Faculty of Psychology, Complutense University of Madrid, Madrid, Spain.ORCID https://orcid.org/0000-0002-9614-4062

Funding

Viral Vector CoreP60AA006420 · NIAAA · SCRIPPS RESEARCH INSTITUTE, THE · PI ERIC P ZORRILLA · 2003 to 2026
$46.3M
SYSTEMIC NEUROPHARMACOLOGYP50AA006420 · NIAAA · SCRIPPS RESEARCH INSTITUTE · PI KOOB, GEORGE F · 1985 to 2002
$5.1M
Activation of the parasubthalamic nucleus in alcohol dependenceR01AA026685 · NIAAA · SCRIPPS RESEARCH INSTITUTE, THE · PI Jeffery Lee Dunning · 2018 to 2026
$3.0M
Adaptations to chronic activation of BK channels by ethanol: Contribution to dependence and toleranceR33AA027636 · NIAAA · SCRIPPS RESEARCH INSTITUTE, THE · PI CONTET, CANDICE · 2022 to 2024
$1.6M
Role of BK channels in alcohol-induced dysmyelinationR01AA032709 · NIAAA · SCRIPPS RESEARCH INSTITUTE, THE · PI Candice Contet · 2025 to 2026
$1.3M
Role of glucocorticoid receptor-mediated mRNA decay in alcohol dependenceR21AA030807 · NIAAA · SCRIPPS RESEARCH INSTITUTE, THE · PI CONTET, CANDICE · 2023 to 2024
$478k
Adaptations to chronic activation of BK channels by ethanol: Contribution to dependence and toleranceR21AA027636 · NIAAA · SCRIPPS RESEARCH INSTITUTE, THE · PI CONTET, CANDICE · 2020 to 2021
$473k
NIAAA NIH HHS P50 AA006420NIAAA NIH HHS P60 AA006420NIAAA NIH HHS R01 AA026685NIAAA NIH HHS R01 AA032709NIAAA NIH HHS R21 AA027636NIAAA NIH HHS R21 AA030807NIAAA NIH HHS R33 AA027636NIH HHS AA006420NIH HHS AA026685NIH HHS AA027636NIH HHS AA030807Spanish Ministry of Science, Innovation, and Universities, supported by FEDER (European Union) PID2021-127256OB-I00Spanish Ministry of Science, Innovation, and Universities, supported by FEDER (European Union) RTI2018-099535-B-I00
6 · The paper itself

Abstract

backgroundMemory impairment is frequent among alcohol use disorder (AUD) patients, and we lack specific biomarkers to detect it. Certain apolipoproteins were linked to cognition, and carrying the APOE4 gene is a vulnerability factor to memory impairment in AUD patients. We explored memory deficits in alcohol-dependent male mice and humans versus controls, and their relationship to Apolipoprotein AI (APOAI), apolipoprotein B (APOB), and apolipoprotein E (APOE) plasma levels.

methodsMale C57BL/6J mice underwent voluntary alcohol drinking (two-bottle choice, 2BC) and chronic intermittent ethanol vapor exposure (CIE) as a model of alcohol dependence; memory was assessed by the Object Location Test (OLT) and Novel Object Recognition Test (NORT). Additionally, male AUD-diagnosed patients were recruited in Spain during an alcohol dishabituation program and assessed by the Wechsler Memory Scale-IV (WMS-IV). Plasma APOAI, APOB, and APOE levels were checked in mice and humans by ELISA kits and Luminex immunoassay technology. APOAI immunolabeling was quantified in mouse brain in early withdrawal and following alcohol consumption.

resultsCIE-2BC mice (n = 8) escalated alcohol consumption compared to Air-2BC controls (n = 11) and showed deficits in spatial memory (OLT) and recognition memory (NORT) while AUD patients (n = 12) showed deficits in verbal and visual memory (WMS-IV) versus controls (n = 16). Higher plasma levels of APOAI were detected in CIE-2BC mice and AUD patients, with no differences in APOB and APOE in animals and humans. Significant negative correlations were found between levels of APOAI, APOB, and APOE and memory function tests/scales in the entire sample, with APOAI showing consistent results in both animals and humans. APOAI immunoreactivity was detected in the mice subfornical organ, but the signal did not differ between experimental groups.

conclusionsBoth CIE-2BC mice and AUD patients exhibited elevated plasma levels of APOAI during early abstinence. APOAI correlated with poorer memory performance in both species, suggesting a potential role for this apolipoprotein in the context of alcohol-induced cognitive impairment.

Indexed as

AlcoholismApolipoprotein A-IMemoryMemory DisordersAdultAnimalsApolipoproteins BApolipoproteins EEthanolHumansMaleMiceMice, Inbred C57BLMiddle AgedApolipoprotein A-IApolipoproteins BApolipoproteins EEthanolalcohol use disorderAPOAIAPOEcognitive impairmentmemory

Identifiers

PMID40846662
PMCPMC12519051

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.